Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dopaminergic Enhancement of Stroke Rehabilitation
NCT05369533Phase 2Completed
- Sponsor
- University of California, Los Angeles
- Start
- Aug 2022
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of levodopa in stroke (3 arms), sponsored by University of California, Los Angeles. Primary endpoint: Action Research Arm Test at 3 months. Started Aug 2022; status: completed.
02
Drugs
levodopa
03
Conditions
stroke
Beyond the preview
Go deeper on NCT05369533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05369533.